

US IPOs, Rentokil and emerging markets: Companies and Markets show
Results season is in full swing, and it’s been another bumper week – with the overwhelming majority positive. But there are always laggards, and this week’s show dives into one of the FTSE 100’s biggest fallers, Rentokil. The pest control business’s shares plunged after its half-year figures. Julian Hofmann explains…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Investors' Chronicle →
The British Stock Riding the SpaceX Boom

The UK Is Still Losing Cheap Stocks to Private Equity Bargain Hunters

The Mega IPO Setup: What SpaceX and OpenAI Really Mean for Your Money

Can YOU time the market? Digging Into Commodities & Mining stocks
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.


